查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1694954

2025年桑格定序全球市场报告

Sanger Sequencing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

桑格定序市场规模预计在未来几年将快速成长。它将以 16.9% 的年复合成长率（CAGR）增长至 2029 年的 61.7 亿美元。预测期内的增长可归因于临床基因组学整合的增加、农业基因组学的扩展、药物安全性和药物基因组学的提高、产前和新生儿筛检的增加以及环境 DNA 分析的增加。预测期内的关键趋势包括技术进步、对次世代定序的需求不断增长、在临床诊断中的应用不断扩大、对基因组学研究的投资不断增加以及在个人化医疗中的应用日益广泛。

预计遗传疾病的增加将在未来几年推动桑格测序市场的成长。遗传疾病（遗传性疾病）是由于个体 DNA（携带遗传讯息的遗传物质）的异常或突变所引起的疾病。桑格定序是一种透过确定特定基因或 DNA 区域中核苷酸（DNA 的组成部分）的确切顺序来诊断这些疾病的方法。例如，2024 年 8 月，英国公共医疗系统国家医疗服务体系报告称，英国约有 2,300 人患有地中海贫血，其中约 800 人患有严重地中海贫血，需要定期输血。因此，遗传疾病的增加正在推动桑格定序市场的成长。

Sanger 定序市场的主要企业正致力于扩大其基因组实验室，以便为英国北部提供快速的 Sanger 定序服务。基因组研究所是进行基因检测和分析的专门机构，旨在研究基因和基因组的结构、功能和遗传，以用于诊断、研究和个人化医疗目的。例如，2023年6月，英国基因组服务提供者Source Genomics宣布将其基因组学实验室扩展到英国北部。此次地理扩展是朝着在英国全国范围内公平提供基因组服务迈出的重要一步，确保全国各地的研究机构都能从更快速的周转时间的高品质桑格测序服务中受益。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场－宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球桑格定序PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球桑格定序市场：成长率分析
  • 全球桑格定序市场表现：规模与成长，2019-2024
  • 全球桑格定序市场预测：规模与成长，2024-2029 年，2034 年
  • 全球桑格定序总目标市场（TAM）

第六章市场区隔

  • 全球桑格定序市场（依定序类型划分）现况及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 霰弹枪定序
  • 标靶基因序列测定
  • 其他序列
  • 全球桑格定序市场（依实验室、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 湿实验室
  • 干燥实验室
  • 全球桑格定序市场研究、现况及预测，2019-2024 年、2024-2029 年、2034 年
  • 内部
  • 外包
  • 全球桑格定序市场：按应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断
  • 生物标记与癌症
  • 生殖健康
  • 个人化医疗
  • 法医学
  • 其他用途
  • 全球桑格定序市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 学术的
  • 政府研究机构
  • 製药公司
  • 生技公司
  • 医院
  • 诊所
  • 全球桑格定序市场、霰弹枪定序细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全基因组霰弹枪定序
  • 元基因组散弹枪定序
  • 全球桑格定序市场、目标基因定序细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 定序子定序
  • EXOME定序
  • 全球桑格定序市场及其他定序细分市场，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 嵌套PCR定序
  • 边定序序（SBS）

第七章 区域和国家分析

  • 全球桑格定序市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球桑格定序市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 桑格定序市场：竞争格局
  • 桑格定序市场：公司简介
    • Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Beckman Coulter
  • PerkinElmer Inc.
  • BGI Group
  • LGC Limited
  • GenScript
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • Macrogen Inc.
  • GENEWIZ Inc.
  • Quintara Biosciences
  • CeMIA SA
  • Source BioScience
  • Microsynth AG
  • Fasteris SA
  • GenHunter Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年桑格定序市场：提供新机会的国家
  • 2029年桑格定序市场：细分领域带来新机会
  • 2029年桑格定序市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r28931

Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.

Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.

The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.75 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing clinical genomics integration, expanded agricultural genomics, increasing drug safety and pharmacogenomics, increasing prenatal and newborn screening, increasing environmental DNA analysis. Major trends in the forecast period include technological advancements, growing demand for next-generation sequencing, increasing applications in clinical diagnostics, rising investments in genomics research, expanding use in personalized medicine.

The increase in genetic illnesses is expected to drive the growth of the Sanger sequencing market in the coming years. Genetic illnesses, or genetic disorders, are medical conditions caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is a method used to diagnose these disorders by determining the precise order of nucleotides (the building blocks of DNA) in a specific gene or DNA region. For example, in August 2024, the National Health Service, a UK-based publicly funded healthcare organization, reported that around 2,300 people in the UK are living with thalassemia, with approximately 800 individuals affected by the severe form of the condition who rely on regular blood transfusions. Thus, the rise in genetic illnesses is fueling the growth of the Sanger sequencing market.

Leading companies in the Sanger sequencing market are focusing on expanding genomic laboratories to offer rapid Sanger sequencing services in the northern UK. Genomic laboratories are specialized facilities for conducting genetic testing and analysis, aimed at studying the structure, function, and inheritance of genes and genomes for purposes such as diagnosis, research, and personalized medicine. In June 2023, for instance, Source Genomics, a UK-based provider of genomic services, announced the expansion of their genomic laboratory to the north of the UK, which will increase their capacity for Sanger sequencing services and reduce data turnaround times. This geographic expansion represents a significant step in providing equitable access to genomic services across the UK, enabling research organizations nationwide to benefit from high-quality Sanger sequencing services with faster turnaround times.

In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sanger Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sanger sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
  • 2) By Laboratory: Wet Labs; Dry Labs
  • 3) By Research: In-House; Outsourced
  • 4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
  • 5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
  • Subsegments:
  • 1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing; Metagenomic Shotgun Sequencing
  • 2) By Targeted Gene Sequencing: Amplicon Sequencing; Exome Sequencing
  • 3) By Other Sequencing: Nested PCR Sequencing; Sequencing By Synthesis (SBS)
  • Companies Mentioned: Hoffmann-La Roche; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sanger Sequencing Market Characteristics

3. Sanger Sequencing Market Trends And Strategies

4. Sanger Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sanger Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sanger Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sanger Sequencing Market Growth Rate Analysis
  • 5.4. Global Sanger Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sanger Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sanger Sequencing Total Addressable Market (TAM)

6. Sanger Sequencing Market Segmentation

  • 6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Other Sequencing
  • 6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wet Labs
  • Dry Labs
  • 6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-House
  • Outsourced
  • 6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
  • 6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic
  • Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals
  • Clinics
  • 6.6. Global Sanger Sequencing Market, Sub-Segmentation Of Shotgun Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Genome Shotgun Sequencing
  • Metagenomic Shotgun Sequencing
  • 6.7. Global Sanger Sequencing Market, Sub-Segmentation Of Targeted Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amplicon Sequencing
  • Exome Sequencing
  • 6.8. Global Sanger Sequencing Market, Sub-Segmentation Of Other Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nested PCR Sequencing
  • Sequencing By Synthesis (SBS)

7. Sanger Sequencing Market Regional And Country Analysis

  • 7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sanger Sequencing Market

  • 8.1. Asia-Pacific Sanger Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sanger Sequencing Market

  • 9.1. China Sanger Sequencing Market Overview
  • 9.2. China Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sanger Sequencing Market

  • 10.1. India Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sanger Sequencing Market

  • 11.1. Japan Sanger Sequencing Market Overview
  • 11.2. Japan Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sanger Sequencing Market

  • 12.1. Australia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sanger Sequencing Market

  • 13.1. Indonesia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sanger Sequencing Market

  • 14.1. South Korea Sanger Sequencing Market Overview
  • 14.2. South Korea Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sanger Sequencing Market

  • 15.1. Western Europe Sanger Sequencing Market Overview
  • 15.2. Western Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sanger Sequencing Market

  • 16.1. UK Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sanger Sequencing Market

  • 17.1. Germany Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sanger Sequencing Market

  • 18.1. France Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sanger Sequencing Market

  • 19.1. Italy Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sanger Sequencing Market

  • 20.1. Spain Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sanger Sequencing Market

  • 21.1. Eastern Europe Sanger Sequencing Market Overview
  • 21.2. Eastern Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sanger Sequencing Market

  • 22.1. Russia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sanger Sequencing Market

  • 23.1. North America Sanger Sequencing Market Overview
  • 23.2. North America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sanger Sequencing Market

  • 24.1. USA Sanger Sequencing Market Overview
  • 24.2. USA Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sanger Sequencing Market

  • 25.1. Canada Sanger Sequencing Market Overview
  • 25.2. Canada Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sanger Sequencing Market

  • 26.1. South America Sanger Sequencing Market Overview
  • 26.2. South America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sanger Sequencing Market

  • 27.1. Brazil Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sanger Sequencing Market

  • 28.1. Middle East Sanger Sequencing Market Overview
  • 28.2. Middle East Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sanger Sequencing Market

  • 29.1. Africa Sanger Sequencing Market Overview
  • 29.2. Africa Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sanger Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Sanger Sequencing Market Competitive Landscape
  • 30.2. Sanger Sequencing Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sanger Sequencing Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter
  • 31.2. PerkinElmer Inc.
  • 31.3. BGI Group
  • 31.4. LGC Limited
  • 31.5. GenScript
  • 31.6. Oxford Nanopore Technologies
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. Macrogen Inc.
  • 31.9. GENEWIZ Inc.
  • 31.10. Quintara Biosciences
  • 31.11. CeMIA SA
  • 31.12. Source BioScience
  • 31.13. Microsynth AG
  • 31.14. Fasteris SA
  • 31.15. GenHunter Corporation

32. Global Sanger Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sanger Sequencing Market

34. Recent Developments In The Sanger Sequencing Market

35. Sanger Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 Sanger Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sanger Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sanger Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer